Fortress Biotech (NASDAQ:FBIOP) Stock Price Down 8.1% – Here’s Why

Fortress Biotech, Inc. (NASDAQ:FBIOP) shares dropped 8.1% during trading on Wednesday . The stock traded as low as $6.34 and last traded at $6.37. Approximately 13,518 shares changed hands during mid-day trading, a decline of 23% from the average daily volume of 17,622 shares. The stock had previously closed at $6.93.

Fortress Biotech Trading Down 2.1 %

The stock has a 50-day moving average of $5.83 and a 200 day moving average of $7.97.

Fortress Biotech Company Profile

Fortress Biotech, Inc, a biopharmaceutical company, develops dermatology, pharmaceutical, and biotechnology products in the United States. The company markets dermatology products, such as Qbrexza a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane capsules for severe recalcitrant nodular acne; Amzeeq for severe acne vulgaris; Zilxi, a topical foam; Exelderm cream and solution for topical use; Targadox an oral doxycycline drug for adjunctive therapy for severe acne; Luxamend; sulconazole nitrate cream and solution for tinea cruris and tinea corporis; and doxycycline hyclate tablet.